IRL 2500 is a potent Endothelin receptor antagonist. IRL 2500 shows IC 50 ?values of 1.3 and 94 nM for ET B ?and ET A ?receptors, respectively. IRL 2500 inhibits ETB?receptor-mediated blood pressure increase and renal vascular resistance in rats?in vivo.